Literature DB >> 27000759

Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Roger W Jelliffe1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27000759     DOI： 10.1007/s40262-016-0381-8

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  10 in total

1.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

2.  Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery.

Authors:  Iona Macdonald; Christine E Staatz; Roger W Jelliffe; Alison H Thomson
Journal:  Ther Drug Monit       Date:  2008-02       Impact factor: 3.681

3.  Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

Review 4.  Digitalis glycosides. Pharmacokinetics and their clinical implications.

Authors:  J E Doherty
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

5.  Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors:  R H Reuning; R A Sams; R E Notari
Journal:  J Clin Pharmacol New Drugs       Date:  1973-04

6.  Optimal sampling times for pharmacokinetic experiments.

Authors:  D Z D'Argenio
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

7.  The role of digitalis pharmacokinetics in converting atrial fibrillation and flutter to regular sinus rhythm.

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2014-05       Impact factor: 6.447

8.  Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.

Authors:  L Bianconi; M Mennuni
Journal:  Am J Cardiol       Date:  1998-09-01       Impact factor: 2.778

9.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial.

Authors:  R H Falk; A A Knowlton; S A Bernard; N E Gotlieb; N J Battinelli
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

10.  A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage.

Authors:  Roger W Jelliffe; Mark Milman; Alan Schumitzky; David Bayard; Michael Van Guilder
Journal:  Ther Drug Monit       Date:  2014-06       Impact factor: 3.681
  10 in total
  1 in total

1.  Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.